CEL-P-TIR-001
0 reference filesTirzepatide ↗
No laboratory files received
CELLIVITY / PRODUCT DOCUMENTS
Trust lives in the details.
Find the original laboratory files connected to a product. Check the declared sample and lot, then follow the record back to the material.
- product records
- 21
- reference files received
- 16
- products with reference files
- 10
Supplier references are available to inspect. Exact CELLIVITY-lot qualification is still pending.
21 matching records
CEL-P-RET-001
1 reference filesRetatrutide ↗
Reference · CELLIVITY lot matching pending
- Retatrutide 10 mg analytical report ↗Declared lot: CS-re10920 · 24 Sep 2025
CEL-P-SEM-001
0 reference filesSemaglutide ↗
No laboratory files received
CEL-P-BPC-001
1 reference filesBPC-157 ↗
Reference · CELLIVITY lot matching pending
- BPC-157 10 mg analytical report ↗Declared lot: 001 · 28 Aug 2025
CEL-P-TB5-001
1 reference filesTB-500 ↗
Reference · CELLIVITY lot matching pending
- TB-500 10 mg analytical report ↗Declared lot: CS-t510820 · 20 Aug 2025
CEL-P-BTB-001
0 reference filesBPC-157 + TB-500 ↗
No laboratory files received
CEL-P-KLW-001
0 reference filesKLOW Blend ↗
No laboratory files received
CEL-P-IPA-001
1 reference filesIpamorelin ↗
Reference · CELLIVITY lot matching pending
- Ipamorelin supplier certificate ↗Declared lot: PEPNEXA-2026-IPA-0447 · 29 Jun 2026
CEL-P-CJC-001
0 reference filesCJC-1295 ↗
No laboratory files received
CEL-P-CIP-001
1 reference filesCJC-1295 No DAC + Ipamorelin ↗
Reference · CELLIVITY lot matching pending
- CJC-1295 No DAC + Ipamorelin analytical report ↗Declared lot: CS-ci10825 · 26 Aug 2025
CEL-P-TES-001
1 reference filesTesamorelin ↗
Reference · CELLIVITY lot matching pending
- Tesamorelin supplier certificate ↗Declared lot: PEPNEXA-2026-TES-0224 · 29 Jul 2026
CEL-P-MOT-001
2 reference filesMOTS-c ↗
Reference · CELLIVITY lot matching pending
- MOTS-c 10 mg analytical report ↗Declared lot: CS-mc10801 · 11 Aug 2025
- MOTS-c 10 mg analytical report ↗Declared lot: 001 · 09 Sep 2025
CEL-P-GHK-001
1 reference filesGHK-Cu ↗
Reference · CELLIVITY lot matching pending
- GHK-Cu 100 mg analytical report ↗Declared lot: CS-gu100715 · 25 Jul 2025
CEL-P-EPI-001
1 reference filesEpitalon ↗
Reference · CELLIVITY lot matching pending
- Epitalon 10 mg analytical report ↗Declared lot: CS-ei10720 · 31 Jul 2025
CEL-P-SMX-001
0 reference filesSemax ↗
No laboratory files received
CEL-P-SLK-001
0 reference filesSelank ↗
No laboratory files received
CEL-P-MT2-001
0 reference filesMelanotan II ↗
No laboratory files received
CEL-P-PT1-001
0 reference filesPT-141 / Bremelanotide ↗
No laboratory files received
CEL-R-HCG-001
0 reference filesHCG ↗
No laboratory files received
CEL-R-NAD-001
6 reference filesNAD+ ↗
Reference · CELLIVITY lot matching pending
- NAD+ 500 mg analytical report ↗Declared lot: CS-nd500805 · 14 Aug 2025
- NAD+ 500 mg supplier certificate ↗Declared lot: PEPNEXA-2026-NAD-0500 · 14 Jul 2026
- NAD+ supplier HPLC image ↗Declared lot: PEPNEXA-2026-NAD-0500 · 14 Jul 2026
- NAD+ supplier mass-spectrum image ↗Declared lot: PEPNEXA-2026-NAD-0500 · 14 Jul 2026
- NAD+ supplier structure sheet ↗Declared lot: PEPNEXA-2026-NAD-0500 · 14 Jul 2026
- NAD+ supplier results sheet ↗Declared lot: PEPNEXA-2026-NAD-0500 · 14 Jul 2026
CEL-R-BAC-001
0 reference filesBacteriostatic Water ↗
No laboratory files received
What a complete record needs
Identity
A name on a label needs an identity method that distinguishes the exact material, sequence or composition.
Purity and content
Purity and quantity per vial answer different questions. Each needs the appropriate method and original report.
A matching lot
The result must link to the actual batch being supplied. A report for another sample remains a reference.
Handling and traceability
Storage, shipment conditions, packaging and records must follow the released material’s specification.
What these files show
The files below are displayed as received. A supplier certificate or reference-sample result is not a completed CELLIVITY batch review. Review the notes on each product page, including any unresolved identity or analytical discrepancies.